Follow
NGS
NGS: (Next-generation sequencing) also known as high-throughput sequencing, is the catch-all term used to illustrate a number of different modern sequencing technologies including: Illumina (Solexa) sequencing. Roche 454 sequencing. Ion torrent: Proton / PGM sequencing.
SEP 19, 2024 | 10:00 AM
In the rapidly evolving field of oncology, precision medicine stands at the forefront of providing personalized patient care. Our upcoming webinar, "Transforming Oncology Diagnostics: I...
SEP 12, 2024 | 8:00 AM
Join this webinar to learn how the Bioscience Core Lab at KAUST has automated their PacBio Kinnex library prep workflow on Opentrons robots to facilitate high-throughput RNA sequencing. Ange...
SEP 11, 2024 | 8:00 AM
Thermo Fisher Scientific has been working with KOLs and leading researchers for over the past 10 years to develop publicly available catalog Axiom microarray and AgriSeq targeted sequencing...
JUL 18, 2024 | 3:00 PM
The most common forms of pediatric tumors are acute leukemia (33%), brain tumors (25%), and lymphomas (15%). Diagnosing these tumors utilizes various tests, including those performed by a pa...
JUN 27, 2024 | 10:00 AM
Variant detection of multiple genes from a single tumor sample requires high-throughput molecular testing. To meet this demand, targeted next-generation sequencing (NGS) panels are useful in...
JUN 26, 2024 | 8:00 AM
This webinar explores the groundbreaking impact of innovative NGS enzymes on reshaping the landscape of next-generation sequencing (NGS) and accelerating NGS democratization in diagnostics....
JUNE 21, 2024 3:30 PM ET
Automated Magbead Extraction accelerates your DNA Library Preparation. Gilson Pipetmax uses robotic scripts developed using PIPETMAX for NGS....
JUN 21, 2024 | 12:00 AM
Rapid detection and identification of microbial pathogens in the laboratory is imperative. However, standard microbiology testing approaches often depend on the recovery and culture of viabl...
JUN 19, 2024 | 3:00 PM
Get insights from leading experts, Dr. Normanno and Prof. Turnbull, as they discuss the implications of large NGS panels, co-mutations, and the introduction of patients harboring germline va...
JUN 19, 2024 | 12:00 PM
Measurable or minimal residual disease (MRD) is the presence of very small numbers of tumor cells which may remain in the body following treatment. MRD testing currently has multiple clinica...
JUN 04, 2024 | 10:30 AM
As one of the earliest partners and the first one in Asia-Pacific region of Berkeley Lights (now Bruker Cellular Analysis), Nona Biosciences has built a state-of-the-art single B cell clonin...
MAY 22, 2024 | 9:00 AM
C.E. CREDITS
Tuberculosis (TB) remains a leading global infectious disease killer, second only to COVID-191. It is an airborne disease caused by Mycobacterium tuberculosis bacteria and is responsible for...
MAY 15, 2024 | 10:30 AM
Next-generation sequencing (NGS) oncology panels are becoming integral in hospital and academic settings to guide patient treatment and enrollment in clinical trials. But as NGS is increasin...
APR 18, 2024 | 8:00 AM
This webinar will demonstrate how the MANTIS and TEMPEST liquid dispensers enable assay automation and miniaturization in various applications such as PCR, NGS, immunoassays, and cell and or...
MAR 21, 2024 | 10:00 AM
Next-generation sequencing (NGS) based liquid biopsy is emerging as standard of care in oncology for comprehensive genomic profiling (CGP) of solid tumors. In this presentation we will showc...
NOV 29, 2023 | 9:00 AM
Tumor genomic profiling can be complicated, especially for diseases that commonly have multiple different genomic biomarkers of interest, such as non-small cell lung cancer (NSCLC) and color...
NOV 14, 2023 | 8:00 AM
RNA-Seq remains a critical and robust methodology in understanding cellular and organismal changes associated with development and disease. Advances in automation have helped reduce the cost...
NOV 08, 2023 | 8:00 AM
SiO2 Materials Science is a company with deep roots in materials science and engineering and a track record of innovative packaging products for pharmaceutical drugs. The company also manufa...
NOV 08, 2023 | 7:30 AM
Numerous studies have shown that homologous recombination deficiency (HRD) is a genome-wide biomarker present in high grade ovarian and breast cancers. A cancer therapeutic class, PARP inhib...
NOV 01, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...
OCT 30, 2023 | 8:00 PM
Description: Join this two-part webinar to learn how capillary electrophoresis (CE) complements sequencing technologies, such as next generation sequencing, that are being used by cancer res...
OCT 26, 2023 | 8:00 AM
In the era of advanced biotechnology, automation plays a crucial role in accelerating cancer research. Next-generation sequencing (NGS) technology has revolutionized cancer research, but lab...
OCT 26, 2023 | 8:00 AM
Description: Join this two-part webinar to learn when capillary electrophoresis is an ideal choice relative to other various sequencing technologies – such as next generation sequencin...
JUN 19, 2024 | 12:00 PM
Measurable or minimal residual disease (MRD) is the presence of very small numbers of tumor cells which may remain in the body following treatment. MRD testing currently has multiple clinica...